1. Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine [J]. Neurology, 2004, 63(12):2240-4.2. Silja Horak, Alexandra Koschak, Herman Stuppner, Jorg Striessnig. Use-dependent block of voltage-gated Cav2.1 Ca2+ channels by petasins and eudesmol isomers [J]. J Pharmacol Exp Ther, 2009, 330(1):220-63. Kan SF, Yu CH, Wu CI, Wang PS. Mechanism of S-petasin-induced apoptosis in androgen-independent prostate cancer cells [J]. Biology of Reproduction, 2005:1284. Peter Houghton, Rui Fang, Isariya Techatanawat ,et al. The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity [J]. Methods, 2007, 42(4):377-875. Huang Dongming, Shen Yaching, Wu Chi, Huang Yaoting, Kung Fanlu, Teng Cheming, et al. Investigation of extrinsic and intrinsic apoptosis pathways of new clerodane diterpenoids in human prostate cancer PC-3 cells [J]. Eur J Pharmacol, 2004, 503(1-3):17-246. Molinari M. Cell cycle checkpoints and their inactivation in human cancer [J]. Cell Prolif, 2000, 33(5):261-747. Andrew W.Murray. Recycling the cell cycle: cyclins revisited [J]. Cell, 2004,116(2):221-348. Richard J Bold , Paula M Termuhlen , David J McConkey . Apoptosis, cancer and cancer therapy [J]. Surg Oncol, 1997, 6(3):133-429. Lara Maria Pasetto, Mario Rosario D'Andrea, Alba Ariela Brandes, Elena Rossi, Silvio Monfardini. The development of platinum compounds and their possible combination [J]. Crit Rev Oncol Hemat, 2006, 60(1):59-7510.Jeremy L. Yap, Shilpa Worlikar, Alexander D.MacKerell,Paul Shapiro, Steven Fletcher. Small-molecule inhibitors of the ERK signaling pathway: Towards novel anticancer therapeutics [J]. ChemMedChem, 2011, 6(1):38-4811. McCubrey JA, Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention [J]. Leukemia, 2003, 17(7):1263-9312. John Lyons, Neil Thompson. Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery [J]. Curr Opin Pharmacol, 2005, 5(4):350-613. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer [J]. Oncogene, 2007, 26(22):3291-310 |